Affinity Wealth Management »

Taysha Gene Therapies shares owned by Affinity Wealth Management

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Affinity Wealth Management from 13F filings

Historical chart of Affinity Wealth Management investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Affinity Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Affinity Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $3.9M 577k 6.81

More positions owned by Affinity Wealth Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Invesco Exchange Traded Fd T S&p Mdcp Momntum (XMMO)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Invesco Exch Traded Fd Tr Ii Dorsey Wrgt Dvlp (PIZ)
Spdr Series Trust St Str Sp Aero (XAR)
Invesco Exchange Traded Fd T S&p500 Eql Ind (RSPN)
Select Sector Spdr Tr St Str Energ Etf (XLE)
Select Sector Spdr Tr St Str Svc Etf (XLC)
Seagate Technology Hldngs Pl Ord Shs (STX)
Ishares Tr Expanded Tech (IGV)
First Tr Exch Traded Fd Iii Pfd Secs Inc Etf (FPE)
NVIDIA Corporation (NVDA)
Dbx Etf Tr Xtrack Msci Euro (DBEZ)
Teradyne (TER)
Alphabet Cap Stk Cl A (GOOGL)

View all positions for Affinity Wealth Management

Top funds holding Taysha Gene Therapies

venBio Select Advisor
RA Capital Management
Goldman Sachs Group
BlackRock
Vestal Point Capital
Morgan Stanley
Rtw Investments
FMR
Vanguard Capital Management
State Street Corporation
Siren
Octagon Capital Advisors
Geode Capital Management
Polar Capital Holdings
MPM Oncology Impact Management

View all funds holding Taysha Gene Therapies